Police constable assaults top official of Belagavi airport

Hubballi, June 8: If everything goes as expected, the railway station in Hubballi, the commercial capital of the state and also the headquarters of South Western Railway (SWR), will have the world’s longest railway platform next year.

E Vijaya, chief public relation officer of SWR, said the work is being done as part of doubling between Hubballi and Bengaluru. 

“At present, Hubballi has five platforms, and the number will be increased to eight. Inspection carriage line is getting converted to full platform. 

Platform No. 1 will be extended from 550m to 1,400m with 10m width. At present, Gorakhpur’s 1,366m platform is the world’s longest facility,” the officer said.

She added that one more entry point is coming up at Gadag Road. “Rs 90 crore is being spent on the works related to full yard, signalling, electrical and building. 

The works, started in November 2019, will be completed in the next one year,” said Vijaya.

Mangaluru, May 23: Criticising the Karnataka government's fresh protocol for management of Covid-19 as expensive, a prominent physician in the city has demanded its withdrawal.

According to Dr B Srinivas Kakkilaya, the protocol released by the Health and Family Welfare Department on May 15 enlists unnecessary and unconfirmed tests and treatments. 

The protocol has classified Covid-19 cases into three categories and has provided for hospitalisation of all three categories of patients, from asymptomatic to the most severely ill.

In a letter to the government, Dr Kakkilaya said: "The protocol suggests several investigations to be done right on the day of admission, including blood counts, liver and renal function tests, chest X Ray, ECG, CT scan of the chest, and other special investigations, all of which, if done, will cost Rs 25,000 per patient."

"In the coming days when lakhs of patients are likely to be infected with SARS CoV2, is it necessary and feasible to hospitalise and test all these patients at Rs 25,000 per person," he questioned.

The treatment options suggested in the protocol are also surprising, he pointed out. "The protocol recommends choloroquine, azithromycin, oseltamivir, zinc and vitamin C for all patients, from asymptomatic to the severely ill, and also anti coagulant injections for many patients. All these would cost at least Rs 5,000 per patient. For severe cases of Covid-19, many unproven and experimental treatments have been suggested, which are very expensive and highly questionable," Dr Kakkilaya notes.

Therefore, this protocol, he asserted was not evidence based and likely to do more harm than good. He said these unnecessarily expensive tests and allowing private companies to conduct trials on Covid-19 patients is likely to be misused by vested interests and must be immediately withdrawn, and instead, a protocol that is evidence-based, simple and avoiding unnecessary expenses, must be developed.